<DOC>
	<DOCNO>NCT00532142</DOCNO>
	<brief_summary>The ROVO study prospective , placebocontrolled randomise study design evaluate effect radial optic neurotomy central vein occlusion , versus triamcinolone acetonide . 240 patient visual acuity &lt; 0.5 Snellen randomise . Patients treat either RON , single intravitreal injection 4 mg triamcinolone acetonide , placebo treatment - `` sham '' injection intravitreal triamcinolone . Patients examine regularly period one year . Best correct visual acuity far near , well clinical examination , fluorescein- indocyanine green angiogram , optical coherence tomography , perimetry , perform pre- postoperatively .</brief_summary>
	<brief_title>The ROVO Study : Radial Optic Neurotomy CVO</brief_title>
	<detailed_description />
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Onset CVO longer 12 month On FLA 1. nonperfused ( great 10 disc area nonperfusion ) 2. perfuse visual acuity lower 0.1 Snellen , 3. perfuse improvement visual acuity 4 week ) â€¢ Dense cataract* ( grade 3 4 ) precludes judgement fundus . Pregnancy Allergy Fluoresceine Indocyanine green Unable come follow visit Presence severe retinopathy Presence advance optic atrophy uncontrolled glaucoma . Visual acuity high 0.5 Snellen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>